Overview
Craig W. Philips is a Founding Partner at Pack Ventures[1] with over twenty years of experience in pharmaceutical and biotechnology sectors[2]. Philips has held executive and board positions across multiple companies, including serving as President of Kineta, Inc. from 2013 to June 2025[8], Board Member and Co-Founder of Abacus Bioscience since 2015[6], and General Partner at Whetstone Ventures LLC since 2014[7]. Currently, Philips serves as Board Member and Chair of PharmaIN, Corp.[4] and as Board Member and Chief Financial Officer of CounterX Therapeutics[3], both positions held since January 2025. Philips holds an MBA from The Ohio State University Fisher College of Business[11] and a Bachelor of Science in Marketing from Ohio State[12], along with professional studies in Pharmaceutical Corporate Strategy from INSEAD[13].
Profile introduction
Senior executive/Board Member with broad based global pharmaceutical/biotechnology experience. Over twenty Years of Big Pharma experience through all stages of drug and corporate evolution. Ten Years of small pharma and start-up experience. Co-Founder/Board member/Advisor for startup companies (PVP Biologics, (sold to Takeda), Abacus Bioscience, MedsForAll, Transcellular Therapeutics) . Today, I am focused on corporate transactions including M&A and strategic transactions, equity financing, developing markets for pharma products, and building and leading highly effective teams. My expertis…
Career history
- Board Member and Chief Financial OfficerJan 2025 to presentCounterX Therapeutics
- Board Member and ChairJan 2025 to presentPharmaIN, Corp.
- Founding Partner2021 to presentPack Ventures
- Board Member, Co-Founder2015 to presentAbacus Bioscience Inc
- General Partner2014 to presentWhetstone Ventures LLC
- President2013 to Jun 2025Kineta, Inc.
- Board Member2021 to 2022CBI Co Ltd
- Entrepreneur-in-Residence2012 to 2017University of Washington
Education
MBA, Masters in Business Administration1982 - 1984The Ohio State University Fisher College of Business
Professional Studies, Pharmaceutical Corporate Strategy1999 - 2003INSEAD
This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.